Net Cash Provided by (Used in) Financing Activities in USD of ABBOTT LABORATORIES from Q1 2010 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Abbott Laboratories quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q1 2010 to Q1 2025.
- Abbott Laboratories Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$2.06B, a 74.7% decline year-over-year.
- Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$5.4B, a 23.8% increase from 2023.
- Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$7.09B, a 7.14% increase from 2022.
- Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$7.64B, a 39% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)